BUSINESS WIRE--St. Jude Medical, Inc. (NYSE:STJ - News) today announced the U.S. launch of its Attune™ Flexible Adjustable Annuloplasty Ring for the repair of diseased heart valves. The company received U.S. Food and Drug Administration clearance and will introduce the product at the annual meeting of the American Association for Thoracic Surgery in Boston, on May 9.
